Publications by authors named "Malek Jemni"
Anti-Saccharomyces cerevisiae antibodies in patients with COVID-19.
Arab J Gastroenterol
November 2022
Article Synopsis
- - The study investigated the presence of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with severe and mild COVID-19 compared to healthy controls.
- - Results showed a significantly higher frequency of ASCA in both severe (21.6%) and mild (13.7%) COVID-19 patients versus healthy individuals (3.7%).
- - The study concluded that ASCA levels were more prevalent in COVID-19 patients, especially those with severe symptoms, suggesting a potential link between COVID-19 and autoimmune diseases.
Objective: This study was conducted to evaluate the frequency of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with rheumatoid arthritis (RA).
Methods: Eighty-three RA patients with positive anti-cyclic citrullinated antibodies (anti-CCP) and 160 healthy blood donors were included in this study. ASCA IgG and IgA were assessed with enzyme-linked immunosorbent assay.